Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
-129K
-
Total reported value, excl. options
-
$87.7M
-
Value change
-
-$6.4M
-
Number of buys
-
38
-
Number of sells
-
-28
-
Price
-
$6.11
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q2 2024
82 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q2 2024.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 27.5M outstanding shares and own 52.31% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic GP LLC (2.41M shares), DG Capital Management, LLC (1.63M shares), Solas Capital Management, LLC (1.34M shares), BlackRock Inc. (1.19M shares), VANGUARD GROUP INC (1.03M shares), HARBERT FUND ADVISORS, INC. (467K shares), STATE STREET CORP (321K shares), GEODE CAPITAL MANAGEMENT, LLC (302K shares), and GENDELL JEFFREY L (283K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.